菲普拉宗和祖师麻片联合治疗类风湿性关节炎162例疗效分析(Philipppe Razon and Zushima tablets for the treatment of rheumatoid arthritis clinical analysis of 162 cases).docVIP

菲普拉宗和祖师麻片联合治疗类风湿性关节炎162例疗效分析(Philipppe Razon and Zushima tablets for the treatment of rheumatoid arthritis clinical analysis of 162 cases).doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
菲普拉宗和祖师麻片联合治疗类风湿性关节炎162例疗效分析(Philipppe Razon and Zushima tablets for the treatment of rheumatoid arthritis clinical analysis of 162 cases)

菲普拉宗和祖师麻片联合治疗类风湿性关节炎162例疗效分析(Philipppe Razon and Zushima tablets for the treatment of rheumatoid arthritis clinical analysis of 162 cases) Philipppe Razon and Zushima tablets for the treatment of rheumatoid arthritis: clinical analysis of 162 cases 2009-04-16 Zhao Jinshan, Zhang Xiaoping, Li Xiang Abstract: Philipppe Razon and Zushima tablets for the treatment of rheumatoid arthritis, according to clinical observation to 162 patients, the curative rate was more than 85%, higher than the two separate application of the excellent rate of 83% and 83.5%. For the early and middle stages of rheumatoid arthritis synovial system occurred in pain and swelling, joint effusion has reliable analgesic and anti-inflammatory effects, the joint function is improved, and the effect on liver and kidney function, gastrointestinal adverse reactions are mild, low price, visible in the combination of the two can be used as a routine medication is safe and effective in the treatment of rheumatoid arthritis arthritis. Key words: rheumatoid arthritis; Philipppe Razon; Zushima tablets; combined therapy; curative effect CLC number: R593.22, document identification code: B Article number:(2000)Treatment of rheumatoid arthritis is to relieve pain, prevent joint damage and preserve or improve joint function, its main use is for non steroidal anti-inflammatory drugs (drugs) slow acting antirheumatic drugs to control the disease progression and pathology (second-line drugs) 1, and the need to take a long time, often because of easy to cause gastrointestinal reactions and gastrointestinal bleeding and treatment interruption. Our department from January 1995 to July 1999 of Shandong Jintai Group production of Philipppe Razon and Hebei Shanhaiguan pharmaceutical factory production of Zushima tablets in the treatment of patients with rheumatoid arthritis in 162 cases, and after 6 months to 3 years of follow-up, with satisfactory pain, swelling and improve curative effect, no gastro

您可能关注的文档

文档评论(0)

jgx3536 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6111134150000003

1亿VIP精品文档

相关文档